| Reliability and initial validation of the ulcerative colitis endoscopic index of severity SPL Travis, D Schnell, P Krzeski, MT Abreu, DG Altman, JF Colombel, ... Gastroenterology 145 (5), 987-995, 2013 | 467 | 2013 |
| A Bayesian credible subgroups approach to identifying patient subgroups with positive treatment effects PM Schnell, Q Tang, WW Offen, BP Carlin Biometrics 72 (4), 1026-1036, 2016 | 68 | 2016 |
| The impact of clinical information on the assessment of endoscopic activity: characteristics of the Ulcerative Colitis Endoscopic Index of Severity [UCEIS] SPL Travis, D Schnell, BG Feagan, MT Abreu, DG Altman, SB Hanauer, ... Journal of Crohn's and Colitis 9 (8), 607-616, 2015 | 64 | 2015 |
| Randomized double-blind placebo-controlled proof-of-concept trial of Resveratrol for outpatient treatment of mild coronavirus disease (COVID-19) MR McCreary, PM Schnell, DA Rhoda Scientific Reports 12 (1), 1-12, 2022 | 42 | 2022 |
| Mitigating unobserved spatial confounding when estimating the effect of supermarket access on cardiovascular disease deaths PM Schnell, G Papadogeorgou Annals of Applied Statistics 14 (4), 2069-2095, 2020 | 32* | 2020 |
| Alleviating confounding in spatio-temporal areal models with an application on crimes against women in India A Adin, T Goicoa, JS Hodges, PM Schnell, MD Ugarte Statistical Modelling 23 (1), 9-30, 2023 | 29 | 2023 |
| A Bayesian Exposure-Time Method for Clinical Trial Safety Monitoring With Blinded Data PM Schnell, G Ball Therapeutic Innovation & Regulatory Science 50 (6), 833-838, 2016 | 28 | 2016 |
| Subgroup inference for multiple treatments and multiple endpoints in an Alzheimer’s disease treatment trial P Schnell, Q Tang, P Müller, BP Carlin The Annals of Applied Statistics 11 (2), 949-966, 2017 | 17 | 2017 |
| Palliative Care Referral Patterns for Adolescent and Young Adult Patients at a Comprehensive Cancer Center BJ Lockwood, OL Ntukidem, SE Ehrman, PM Schnell, DL Klemanski, ... Journal of Adolescent and Young Adult Oncology 10 (1), 109-114, 2021 | 16 | 2021 |
| Activity of estrogen receptor β agonists in therapy-resistant estrogen receptor-positive breast cancer J Datta, N Willingham, JM Manouchehri, P Schnell, M Sheth, JJ David, ... Frontiers in Oncology 12, 857590, 2022 | 14 | 2022 |
| Multiplicity-adjusted semiparametric benefiting subgroup identification in clinical trials PM Schnell, P Müller, Q Tang, BP Carlin Clinical Trials 15 (1), 75-86, 2018 | 13 | 2018 |
| Evaluation of a Rapid Assessment Questionnaire Using a Biomarker for Dietary Intake of n‐3 Fatty Acids A Angelotti, RM Cole, PM Schnell, SK Raatz, MA Belury Lipids 54 (5), 321-328, 2019 | 11 | 2019 |
| Higher tumor mass and lower adipose mass are associated with colon‑26 adenocarcinoma‑induced cachexia in male, female and ovariectomized mice T Banh, D Snoke, RM Cole, A Angelotti, PM Schnell, MA Belury Oncology reports 41 (5), 2909-2918, 2019 | 11 | 2019 |
| Blinded Safety Signal Monitoring for the FDA IND Reporting Final Rule G Ball, PM Schnell Statistical Applications from Clinical Trials and Personalized Medicine to …, 2016 | 10 | 2016 |
| Bayesian credible subgroup identification for treatment effectiveness in time-to-event data D Ngo, R Baumgartner, S Mt-Isa, D Feng, J Chen, P Schnell Plos one 15 (2), e0229336, 2020 | 8 | 2020 |
| Modeling the role of carrier and mobile herds on foot-and-mouth disease virus endemicity in the Far North Region of Cameroon PM Schnell, Y Shao, LW Pomeroy, JH Tien, M Moritz, R Garabed Epidemics 29, 100355, 2019 | 8 | 2019 |
| A marginal cure rate proportional hazards model for spatial survival data P Schnell, D Bandyopadhyay, BJ Reich, M Nunn Journal of the Royal Statistical Society: Series C (Applied Statistics) 64 …, 2015 | 8 | 2015 |
| Monitoring SARS-COV-2 transmission and prevalence in populations under repeated testing M Wascher, PM Schnell, WR Khudabukhsh, M Quam, JH Tien, ... medRxiv, 2021.06. 22.21259342, 2021 | 7 | 2021 |
| A Framework for Safety Evaluation Throughout the Product Development Life-Cycle G Ball, T Reblin, J Buchanan, BA Hendrickson, E Lewis, PM Schnell, ... Therapeutic Innovation & Regulatory Science, 1-10, 2019 | 7 | 2019 |
| Examining the Association of Billed Advance Care Planning With End-of-Life Hospital Admissions Among Advanced Cancer Patients in Hospice LC Prater, B O’Rourke, P Schnell, W Xu, Y Li, J Gustin, B Lockwood, ... American Journal of Hospice and Palliative Medicine® 39 (5), 504-510, 2022 | 6 | 2022 |
